Cargando…
Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade
Despite major advances in immunotherapy, hepatocellular carcinoma (HCC) remains a challenging target. Natural Killer (NK) cells are crucial components of the anti-HCC immune response, which can be manipulated for immunotherapeutic benefit as primary targets, modulators of the tumour microenvironment...
Autores principales: | Bozward, Amber G., Warricker, Frazer, Oo, Ye H., Khakoo, Salim I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120158/ https://www.ncbi.nlm.nih.gov/pubmed/33995362 http://dx.doi.org/10.3389/fimmu.2021.643310 |
Ejemplares similares
-
The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma
por: Warricker, Frazer, et al.
Publicado: (2021) -
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease
por: Richardson, N., et al.
Publicado: (2022) -
High-Energy Physics Options for the Next Decades
por: Blaising, J J, et al.
Publicado: (2006) -
Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma
por: Zhuang, Lihui, et al.
Publicado: (2018) -
Hepatitis B viral replication influences the expression of natural killer cell ligands
por: Koumbi, Lemonica, et al.
Publicado: (2016)